TickerFacts.

HeartBeam, Inc. (BEATW): Capital Expenditures

Annual figures by period end, from SEC filings.

$600.0K
Year ended 2025-12-31
$993.0K
Trailing 12 months to 2026-06-30
2022-12-31: $02023-12-31: $256.0K2024-12-31: $201.0K2025-12-31: $600.0K$600.0K
2022-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$600.0K+198.5%2026-03-12, From 2025-01-01
2024-12-31$201.0K-21.5%2026-03-12, From 2024-01-01
2023-12-31$256.0Kn/a2025-03-13, From 2023-01-01
2022-12-31$0n/a2024-03-20, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
HeartBeam, Inc. (BEATW)2025-12-31$600.0K+198.5%
Aethlon Medical Inc (AEMD)2026-03-31$3.7Kn/a
QTREX Quantum Ltd. (QTEX)2025-12-31$103.0K-37.2%
Medinotec Inc. (MDNC)2026-02-28$1.4K-98.5%
Bluejay Diagnostics, Inc. (BJDX)2025-12-31$173.7K-43.4%
Autonomix Medical, Inc. (AMIX)2026-03-31$10.0K-28.6%
Glucotrack, Inc. (GCTK)2025-12-31$96.0K-7.7%
RenovoRx, Inc. (RNXT)2025-12-31$2.0K-83.3%
Profusa, Inc. (PFSA)2025-12-31$8.0Kn/a

Compare BEATW, AEMD, QTEX, MDNC side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗